Limits...
The prevalence of COPD co-morbidities in Serbia: results of a national survey.

Nagorni-Obradovic LM, Vukovic DS - NPJ Prim Care Respir Med (2014)

Bottom Line: Information on the health of the population was obtained from interviews and anthropometric measurements.In this study we analysed a total of 10,013 respondents aged 40 years or older.Out of the 10,013 respondents, 5,377 were aged 40-59 years and 4,636 were 60 years or older.

View Article: PubMed Central - PubMed

Affiliation: 1] Faculty of Medicine, University of Belgrade, Belgrade, Serbia [2] Clinic for Pulmonology, Clinical Centre of Serbia, Belgrade, Serbia.

ABSTRACT

Background: Research studies have found different prevalence rates for co-morbidities in patients with chronic obstructive pulmonary disease (COPD).

Aims: The aim of our study was to investigate the prevalence of co-morbidities as well as functional limitations in subjects with COPD.

Methods: The study was based on a nationally representative sample of the population of Serbia. Information on the health of the population was obtained from interviews and anthropometric measurements. In this study we analysed a total of 10,013 respondents aged 40 years or older. There were 653 subjects with COPD and 9,360 respondents without COPD.

Results: Out of the 10,013 respondents, 5,377 were aged 40-59 years and 4,636 were 60 years or older. The prevalence of COPD was 5.0% in respondents aged 40-59 years and 8.3% in those aged 60 years or older; the total prevalence was 6.5%. The most prevalent co-morbidities among respondents with COPD were hypertension (54.5%) and dyslipidaemia (26.5%). The prevalence of all analysed co-morbidities was higher in respondents with COPD and the difference was highly statistically significant, except for stroke and malignancies, for which the difference was significant. Analysis showed that respondents with COPD had a higher prevalence of all analysed clinical factors (dizziness, obesity, anaemia and frailty) and functional impairments (mobility and hearing and visual impairment) compared with respondents without COPD. For those aged 40-59 years the difference was highest for mobility difficulty (four times higher prevalence in COPD patients) and anaemia (three times higher in COPD patients).

Conclusion: Our analysis showed that the most prevalent co-morbidities in COPD were hypertension, dyslipidaemia, chronic renal disease and anxiety/depression. The finding suggests that health professionals should actively assess co-morbidities in patients with COPD.

Show MeSH

Related in: MedlinePlus

Selection of respondents.
© Copyright Policy - open-access
Related In: Results  -  Collection

License
getmorefigures.php?uid=PMC4373300&req=5

fig1: Selection of respondents.

Mentions: The Institute of Public Health conducted a multipurpose health survey of the population of Serbia (excluding Kosovo) in 2006. A stratified two-stage randomised sample of all registered households in Serbia was used. The sample was selected to provide statistically reliable estimates of health at the national level and the sample was representative for the population of Serbia as a whole, as well as for urban and rural areas and for males and females. Information on the health of the population was obtained from interviews and anthropometric and blood pressure measurements. Interviews were performed in households of the respondents by a team consisting of one trained interviewer and a health worker who recorded anthropometric and blood pressure measurements. Out of 7,673 households selected, 6,156 were interviewed. The household response rate was 86.5%. In the households, there were 15,563 adults aged ⩾20 years, of whom 14,522 were interviewed, yielding a response rate of 93.3%. The overall response rate for adults was 80.5%. All adults aged 20 years and above were included, except those living in institutions (Figure 1).


The prevalence of COPD co-morbidities in Serbia: results of a national survey.

Nagorni-Obradovic LM, Vukovic DS - NPJ Prim Care Respir Med (2014)

Selection of respondents.
© Copyright Policy - open-access
Related In: Results  -  Collection

License
Show All Figures
getmorefigures.php?uid=PMC4373300&req=5

fig1: Selection of respondents.
Mentions: The Institute of Public Health conducted a multipurpose health survey of the population of Serbia (excluding Kosovo) in 2006. A stratified two-stage randomised sample of all registered households in Serbia was used. The sample was selected to provide statistically reliable estimates of health at the national level and the sample was representative for the population of Serbia as a whole, as well as for urban and rural areas and for males and females. Information on the health of the population was obtained from interviews and anthropometric and blood pressure measurements. Interviews were performed in households of the respondents by a team consisting of one trained interviewer and a health worker who recorded anthropometric and blood pressure measurements. Out of 7,673 households selected, 6,156 were interviewed. The household response rate was 86.5%. In the households, there were 15,563 adults aged ⩾20 years, of whom 14,522 were interviewed, yielding a response rate of 93.3%. The overall response rate for adults was 80.5%. All adults aged 20 years and above were included, except those living in institutions (Figure 1).

Bottom Line: Information on the health of the population was obtained from interviews and anthropometric measurements.In this study we analysed a total of 10,013 respondents aged 40 years or older.Out of the 10,013 respondents, 5,377 were aged 40-59 years and 4,636 were 60 years or older.

View Article: PubMed Central - PubMed

Affiliation: 1] Faculty of Medicine, University of Belgrade, Belgrade, Serbia [2] Clinic for Pulmonology, Clinical Centre of Serbia, Belgrade, Serbia.

ABSTRACT

Background: Research studies have found different prevalence rates for co-morbidities in patients with chronic obstructive pulmonary disease (COPD).

Aims: The aim of our study was to investigate the prevalence of co-morbidities as well as functional limitations in subjects with COPD.

Methods: The study was based on a nationally representative sample of the population of Serbia. Information on the health of the population was obtained from interviews and anthropometric measurements. In this study we analysed a total of 10,013 respondents aged 40 years or older. There were 653 subjects with COPD and 9,360 respondents without COPD.

Results: Out of the 10,013 respondents, 5,377 were aged 40-59 years and 4,636 were 60 years or older. The prevalence of COPD was 5.0% in respondents aged 40-59 years and 8.3% in those aged 60 years or older; the total prevalence was 6.5%. The most prevalent co-morbidities among respondents with COPD were hypertension (54.5%) and dyslipidaemia (26.5%). The prevalence of all analysed co-morbidities was higher in respondents with COPD and the difference was highly statistically significant, except for stroke and malignancies, for which the difference was significant. Analysis showed that respondents with COPD had a higher prevalence of all analysed clinical factors (dizziness, obesity, anaemia and frailty) and functional impairments (mobility and hearing and visual impairment) compared with respondents without COPD. For those aged 40-59 years the difference was highest for mobility difficulty (four times higher prevalence in COPD patients) and anaemia (three times higher in COPD patients).

Conclusion: Our analysis showed that the most prevalent co-morbidities in COPD were hypertension, dyslipidaemia, chronic renal disease and anxiety/depression. The finding suggests that health professionals should actively assess co-morbidities in patients with COPD.

Show MeSH
Related in: MedlinePlus